Prawo i regulacje · 30/07/2015

Apertus Pharmaceuticals Seeks DEA Registration for Controlled Substances Manufacturing

Apertus Pharmaceuticals has submitted a request to the Drug Enforcement Administration (DEA) for registration as a manufacturer of controlled substances, a move that, if approved, will grant the company permission to produce and distribute these substances.